A meta-analysis of 10,362 patients with inflammatory bowel disease has found that GLP-1 receptor agonists are safe and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback